Rhythm Pharmaceuticals Statistics
Total Valuation
RYTM has a market cap or net worth of $8.01 billion. The enterprise value is $7.79 billion.
| Market Cap | 8.01B |
| Enterprise Value | 7.79B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RYTM has 68.85 million shares outstanding. The number of shares has increased by 8.09% in one year.
| Current Share Class | 68.85M |
| Shares Outstanding | 68.85M |
| Shares Change (YoY) | +8.09% |
| Shares Change (QoQ) | +0.91% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 88.92% |
| Float | 54.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.38 |
| Forward PS | 18.99 |
| PB Ratio | 75.41 |
| P/TBV Ratio | 79.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 31.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.51.
| Current Ratio | 3.45 |
| Quick Ratio | 3.00 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.86 |
Financial Efficiency
Return on equity (ROE) is -117.04% and return on invested capital (ROIC) is -43.64%.
| Return on Equity (ROE) | -117.04% |
| Return on Assets (ROA) | -30.96% |
| Return on Invested Capital (ROIC) | -43.64% |
| Return on Capital Employed (ROCE) | -63.96% |
| Weighted Average Cost of Capital (WACC) | 15.08% |
| Revenue Per Employee | $579,512 |
| Profits Per Employee | -$507,783 |
| Employee Count | 414 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.07 |
Taxes
In the past 12 months, RYTM has paid $1.07 million in taxes.
| Income Tax | 1.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +22.10% in the last 52 weeks. The beta is 1.97, so RYTM's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | +22.10% |
| 50-Day Moving Average | 103.40 |
| 200-Day Moving Average | 99.11 |
| Relative Strength Index (RSI) | 61.68 |
| Average Volume (20 Days) | 697,269 |
Short Selling Information
The latest short interest is 9.57 million, so 13.91% of the outstanding shares have been sold short.
| Short Interest | 9.57M |
| Short Previous Month | 9.67M |
| Short % of Shares Out | 13.91% |
| Short % of Float | 17.56% |
| Short Ratio (days to cover) | 9.02 |
Income Statement
In the last 12 months, RYTM had revenue of $239.92 million and -$210.22 million in losses. Loss per share was -$3.12.
| Revenue | 239.92M |
| Gross Profit | 213.53M |
| Operating Income | -200.63M |
| Pretax Income | -204.28M |
| Net Income | -210.22M |
| EBITDA | -199.55M |
| EBIT | -200.63M |
| Loss Per Share | -$3.12 |
Balance Sheet
The company has $330.90 million in cash and $109.78 million in debt, with a net cash position of $221.11 million or $3.21 per share.
| Cash & Cash Equivalents | 330.90M |
| Total Debt | 109.78M |
| Net Cash | 221.11M |
| Net Cash Per Share | $3.21 |
| Equity (Book Value) | 217.30M |
| Book Value Per Share | 1.50 |
| Working Capital | 302.98M |
Cash Flow
In the last 12 months, operating cash flow was -$105.35 million and capital expenditures -$953,000, giving a free cash flow of -$106.30 million.
| Operating Cash Flow | -105.35M |
| Capital Expenditures | -953,000 |
| Depreciation & Amortization | 1.08M |
| Net Borrowing | n/a |
| Free Cash Flow | -106.30M |
| FCF Per Share | -$1.54 |
Margins
Gross margin is 89.00%, with operating and profit margins of -83.62% and -85.59%.
| Gross Margin | 89.00% |
| Operating Margin | -83.62% |
| Pretax Margin | -85.14% |
| Profit Margin | -85.59% |
| EBITDA Margin | -83.17% |
| EBIT Margin | -83.62% |
| FCF Margin | n/a |
Dividends & Yields
RYTM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.09% |
| Shareholder Yield | -8.09% |
| Earnings Yield | -2.71% |
| FCF Yield | -1.37% |
Analyst Forecast
The average price target for RYTM is $141.53, which is 21.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $141.53 |
| Price Target Difference | 21.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 67.57% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RYTM has an Altman Z-Score of 12.89 and a Piotroski F-Score of 4.
| Altman Z-Score | 12.89 |
| Piotroski F-Score | 4 |